For the millions already living in the late stages of dementia—and for those who love and tend to them—the medical world has long offered more hope for prevention than for presence. Researchers at the University of Kentucky's Sanders-Brown Center on Aging have now turned toward that neglected terrain, presenting clinical evidence that a cannabis-derived treatment can meaningfully reduce agitation in advanced dementia patients, while simultaneously launching a free digital resource designed to guide families through the daily realities of late-stage care. Together, these efforts represent a qui
New cannabis-based treatment shows promise for late-stage dementia agitation
Millions of people living with advanced dementia and their family caregivers face significant burden from agitation and complex care needs with limited treatment options.